© Reuters.
Eli Lilly (NYSE:), Amazon lead Tuesday's market cap stock movers
Article Content:
Tuesday's trading session is witnessing notable moves among stocks, particularly in the mega-cap and large-cap sectors. Eli Lilly and Amazon are among the gainers, while Advanced Micro Devices (NASDAQ:) and Morgan Stanley (NYSE:) see declines. Here are the details on some of the most significant stock movers across market cap categories.
Mega-Cap Movers (Market Cap $200B+):
- Eli Lilly and Co (LLY); Buy with Prime Expands with Launch of New Merchant SteveMadden.com: +5.21%
- Amazon Com Inc (NASDAQ:): +2.71%
- Wal-mart Stores (NYSE:): +2.26%
- Morgan Stanley (MS); HSBC downgrades Morgan Stanley stock to Hold, sees 3% downside after 29% rise: -1.98%
- Adv Micro Device (AMD): -2.62%
Large-Cap Stock Movers (Market Cap $10B-$200B):
- Sarepta (SRPT); Arrowhead Pharmaceuticals (NASDAQ:) Announces Global License and Collaboration Agreement with Sarepta Therapeutics (NASDAQ:) for Multiple Clinical and Preclinical Programs: +11.87%
- Exact Sciences Co (NASDAQ:); Exact Sciences Advances Breast Cancer Care with the Oncotype DX ® test and Genomic Profiling Research at SABCS 2024: +9.17%
- NRG Energy Inc (NYSE:); NRG Energy stock rating upgraded to buy, target lifted on cross-selling strategy: +8.71%
- MicroStrategy Inc (NASDAQ:): -9.7%
- Gen Motors (NYSE:): -8.4%
Mid-Cap Stock Movers (Market Cap $2B-$10B):
- Semtech Corp (NASDAQ: (NASDAQ:)); Semtech stock soars 9% on strong earnings and outlook: +17.74%
- Arrowhead Research Corp (ARWR): +16.29%
- Fluence Energy (FLNC); Fluence Energy stock jumps 3% on earnings beat, strong guidance: -17.15%
- Kohls Corp (NYSE:); Kohl's Reports Third Quarter Fiscal 2024 Financial Results: -15.13%
- Belite Bio ADR (BLTE): -14.39%
Small-Cap Stock Movers (Market Cap $300M-$2B):
- Hesai ADR (HSAI): +61.16%
- Alector Inc (NASDAQ:); Alector halts Alzheimer's trial after missing primary endpoint: -35.23%
- Leslies Inc (LESL); Leslie's, Inc. Announces Fourth Quarter & Fiscal 2024 Financial Results; Provides First Quarter Fiscal 2025 Outlook: -32.05%
- Embecta (EMBC); Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructu: +32.34%
- LexinFintech (NASDAQ:); LexinFintech Holdings Ltd. Reports Third Quarter 2024 Unaudited Financial Results: +26.32%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.